Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
durvalumab
×
30 days
×
Clear all
Filters
3
NCT06606847
2026-03-18
LADOGA
AstraZeneca
Phase 2
Active not recruiting
30 enrolled
NCT05941897
2026-03-05
LOTOS
AstraZeneca
Phase 2
Active not recruiting
39 enrolled
NCT05063565
2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled